BSEBoard Meeting28 Jul 2026 · 28 Jul 2026, 06:47 pm

Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2026 ,inter alia, to consider and approve Prior intimation of Board Meeting ....

Orchid Pharma Ltd · 524372

✦ AI Summaryboard_meeting

Orchid Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2026, inter alia, to consider and approve prior intimation of board meeting.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Orchid Pharma Ltd - 524372 - Board Meeting Intimation for Prior Intimation Of Board Meeting Scheduled To Be Held On August 01, 2026

Attachments (1)

📄

eef9b3df-bcfa-4ab4-a55f-65f144f87c7e.pdf

pdf

Download →
View document text
OrchidPharm~~ -- A Dhanuka Group Company ---------------------------------- July 28, 2026 National Stock Exchange of India Limited, BSE Limited Exchange Plaza, Bandra Kurla Complex Phiroze Jeejeebhoy Towers, Bandra (E), Mumbai-400051 Dalal Street, Fort, Mumbai- 400001 Symbol: ORCHPHARMA Scrip Code: 524372 Ref: Regulation 29 of Securitie~ and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended Sub: Prior Intimation of Board Meeting scheduled to be held on August 01, 2026 Dear Sir/Madam, This is in continuation to our earlier intimation dated July 10, 2026 and in accordance with Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, this is to intimate that the meeting of Board of Directors of Orchid Pharma Limited ("the Company") is scheduled to be held on Saturday, August 01, 2026, inter alia, for allotment of fully paid up equity shares of Rs. 10 each of the company to eligible shareholders of Dhanuka Laboratories Limited ("amalgamating company") as on record date July 23, 2026, pursuant to the Scheme of Amalgamation of Dhanuka Laboratories Limited ("Amalgamating Company") with Orchid Pharma Limited ("Amalgamated Company/Company") ("the Scheme") You are requested to take the above intimation on record. Thanking You, For Orchid Pharma Limited Kapil Dayya Company Secretary & compliance officer Mem No.: F10698 +91-44-27444471/72/73 corporate@orchidpharma.com orchidpharma.com CIN: L24222TN1992PLC022994 Registered Office: Corporate Office: Orchid Pharma Limited 15th Floor, Tower 1, DLF Corporate Greens, Sector 74A, Plot Nos. 121-128, 128A-133, 138-151, 159-164, SIDCO Industrial Estate, Gurugram - 122004, Haryana, India Alathur, Chengalpattu Dist - 603110, Tamil Nadu, India.